Modeling Cancer with Pluripotent Stem Cells

被引：28

作者：

Gingold, Julian ^{[1
]}

Zhou, Ruoji ^{[2
,3
]}

Lemischka, Ihor R. ^{[4
,5
,6
]}

Lee, Dung-Fang ^{[2
,3
,7
]}

机构：

[1] Cleveland Clin Fdn, Womens Hlth Inst, Cleveland, OH 44195 USA

[2] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA

[3] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA

[4] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA

[5] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA

[6] Icahn Sch Med Mt, Black Family Stem Cell Inst, New York, NY 10029 USA

[7] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell & Regenerat Med, Brown Fdn, Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA

来源：

TRENDS IN CANCER | 2016年 / 2卷 / 09期

关键词：

TARGETED GENE CORRECTION; FUNCTIONAL HUMAN LIVER; KIDNEY ORGANOIDS; HUMAN ES; DIRECTED DIFFERENTIATION; PROGENITOR CELLS; SELF-RENEWAL; IPS CELLS; GENERATION; DISEASE;

D O I：

10.1016/j.trecan.2016.07.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The elucidation of cancer pathogenesis has been hindered by limited access to patient samples, tumor heterogeneity, and the lack of reliable model organisms. Characterized by their ability to self-renew indefinitely and differentiate into all adult cell lineages of an organism, pluripotent stem cells (PSCs), including ESCs and induced pluripotent stem cells (iPSCs), provide a powerful and unlimited source to generate differentiated cells that can be used to study disease biology, facilitate drug discovery and development, and provide key insights for developing personalized therapies. This article reviews the recent developments and technologies converting PSCs into clinically relevant model systems for cancer research.

引用

页码：485 / 494

页数：10

共 50 条

[21] Modeling of osteosarcoma with induced pluripotent stem cells
Pang, Lon Kai
Pena, Mezthly
Zhao, Ruiying
Lee, Dung-Fang
STEM CELL RESEARCH, 2020, 49
[22] Cyclin A1 Is Essential for Setting the Pluripotent State and Reducing Tumorigenicity of Induced Pluripotent Stem Cells
McLenachan, Samuel
Menchon, Cristina
Raya, Angel
Consiglio, Antonella
Edel, Michael J.
STEM CELLS AND DEVELOPMENT, 2012, 21 (15) : 2891 - 2899
[23] Differential Modeling of Fragile X Syndrome by Human Embryonic Stem Cells and Induced Pluripotent Stem Cells
Urbach, Achia
Bar-Nur, Ori
Daley, George Q.
Benvenisty, Nissim
CELL STEM CELL, 2010, 6 (05) : 407 - 411
[24] Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine
Nostro, Maria Cristina
Keller, Gordon
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2012, 23 (06) : 701 - 710
[25] Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells
Xu, Xiao-hong
Zhong, Zhong
ACTA PHARMACOLOGICA SINICA, 2013, 34 (06) : 755 - 764
[26] Using induced pluripotent stem cells for modeling Parkinson's disease
Ke, Minjing
Chong, Cheong-Meng
Su, Huanxing
WORLD JOURNAL OF STEM CELLS, 2019, 11 (09): : 634 - 649
[27] Modeling brain and neural crest neoplasms with human pluripotent stem cells
Schloo, Cedar
Kutscher, Lena M.
NEURO-ONCOLOGY, 2023, 25 (07) : 1225 - 1235
[28] Improved Hepatic Differentiation Strategies for Human Induced Pluripotent Stem Cells
Sgodda, M.
Moebus, S.
Hoepfner, J.
Sharma, A. D.
Schambach, A.
Greber, B.
Ott, M.
Cantz, T.
CURRENT MOLECULAR MEDICINE, 2013, 13 (05) : 842 - 855
[29] Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells
Zhang, Pengbo
Xia, Ninuo
Pera, Renee A. Reijo
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2014, (91):
[30] Novel Insights into Disease Modeling Using Induced Pluripotent Stem Cells
Egashira, Toru
Yuasa, Shinsuke
Fukuda, Keiichi
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (02) : 182 - 188

← 1 2 3 4 5 →